180 Life Sciences Corp. recently approved the grant of stock options totaling 965,000 shares of common stock to various members of the company. The breakdown includes 410,000 shares to CEO Blair Jordan, 25,000 shares to Chief Accounting Officer Eric R. Van Lent, 255,000 shares to Lead Director Ryan Smith, 165,000 shares to Director Stephen H. Shoemaker, and 110,000 shares to Director Dr. Lawrence Steinman. These grants were made as consideration for services rendered and to be rendered to the company. The document does not specify the price of these transactions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.